这是一篇来自已证抗体库的有关Caenorhabd.. mpk 1的综述，是根据28篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合mpk 1 抗体。
mpk 1 同义词: Mitogen-activated protein kinase mpk-1

赛默飞世尔
兔 多克隆
  • 免疫印迹; 人类; 图 1d
赛默飞世尔 mpk 1抗体（Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 1d). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 1b
赛默飞世尔 mpk 1抗体（Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 1b). Int J Oncol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 s3b
  • 免疫印迹; 小鼠; 图 5e
赛默飞世尔 mpk 1抗体（生活技术, 44-680G)被用于被用于免疫印迹在人类样本上 (图 s3b) 和 被用于免疫印迹在小鼠样本上 (图 5e). Nat Immunol (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 4
赛默飞世尔 mpk 1抗体（Invitrogen, 44680G)被用于被用于免疫印迹在人类样本上 (图 4). Nat Commun (2016) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 图 3
  • 免疫印迹; 人类; 图 1
赛默飞世尔 mpk 1抗体（Invitrogen, 44680G)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 1). BMC Cancer (2016) ncbi
兔 多克隆
  • 免疫印迹; 大鼠; 图 5
赛默飞世尔 mpk 1抗体（Invitrogen, 44-680G)被用于被用于免疫印迹在大鼠样本上 (图 5). Mol Biol Cell (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3
赛默飞世尔 mpk 1抗体（Invitrogen, 44680G)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3). Int J Mol Sci (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 3
赛默飞世尔 mpk 1抗体（Thermo Fisher Scientific, 44-680G)被用于被用于免疫印迹在人类样本上 (图 3). Biomed Res Int (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 1
赛默飞世尔 mpk 1抗体（Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 1). Oncogene (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛默飞世尔 mpk 1抗体（Invitrogen, 44680G)被用于被用于免疫印迹在人类样本上浓度为1:1000. Biochem Pharmacol (2015) ncbi
兔 多克隆
  • 免疫细胞化学; 大鼠; 图 1
赛默飞世尔 mpk 1抗体（生活技术, 44680G)被用于被用于免疫细胞化学在大鼠样本上 (图 1). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫印迹; 小鼠; 1:2000; 图 5b
赛默飞世尔 mpk 1抗体（Biosource, 44-680G)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5b). Nat Cell Biol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 4
赛默飞世尔 mpk 1抗体（Invitrogen Life Technologies, 44680G)被用于被用于免疫印迹在人类样本上 (图 4). Cell Death Dis (2015) ncbi
兔 单克隆（K.913.4）
  • 免疫组化-石蜡切片; 斑马鱼
  • 免疫印迹; 斑马鱼
赛默飞世尔 mpk 1抗体（Pierce, MA5-15134)被用于被用于免疫组化-石蜡切片在斑马鱼样本上 和 被用于免疫印迹在斑马鱼样本上. Cell Res (2014) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:50; 图 6
  • 免疫印迹; 人类; 1:1000; 图 4
赛默飞世尔 mpk 1抗体（Invitrogen, 44-680G)被用于被用于免疫组化在人类样本上浓度为1:50 (图 6) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Arch Immunol Ther Exp (Warsz) (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
赛默飞世尔 mpk 1抗体（BioSource, 44-680G)被用于被用于免疫印迹在人类样本上浓度为1:1000. Rheumatology (Oxford) (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 7
赛默飞世尔 mpk 1抗体（Invitrogen, 44680G)被用于被用于免疫印迹在人类样本上 (图 7). PLoS ONE (2013) ncbi
兔 多克隆
  • 免疫细胞化学; 秀丽隐杆线虫; 图 7
赛默飞世尔 mpk 1抗体（Invitrogen, 44680G)被用于被用于免疫细胞化学在秀丽隐杆线虫样本上 (图 7). Nat Cell Biol (2011) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 3
赛默飞世尔 mpk 1抗体（Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 3). J Biol Chem (2011) ncbi
兔 多克隆
  • 免疫组化; 人类; 0.5 ug/ul; 图 1
赛默飞世尔 mpk 1抗体（Biosource, 44-680G)被用于被用于免疫组化在人类样本上浓度为0.5 ug/ul (图 1). Eur J Oral Sci (2010) ncbi
兔 多克隆
  • 免疫细胞化学; 大鼠; 1:50; 图 3
  • 免疫印迹; 大鼠; 图 3
赛默飞世尔 mpk 1抗体（Biosource, 44-680G)被用于被用于免疫细胞化学在大鼠样本上浓度为1:50 (图 3) 和 被用于免疫印迹在大鼠样本上 (图 3). PLoS ONE (2010) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000; 图 1
赛默飞世尔 mpk 1抗体（Invitrogen, 44680G)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Mol Cancer Res (2010) ncbi
兔 多克隆
赛默飞世尔 mpk 1抗体（BioSource, 44-680G)被用于. J Oral Pathol Med (2008) ncbi
兔 多克隆
赛默飞世尔 mpk 1抗体（Invitrogen, 44-680G)被用于. Anal Biochem (2008) ncbi
兔 多克隆
赛默飞世尔 mpk 1抗体（Biosource, 44-680)被用于. Exp Cell Res (2008) ncbi
兔 多克隆
赛默飞世尔 mpk 1抗体（Biosource, 44-680G)被用于. J Cell Biochem (2007) ncbi
兔 多克隆
赛默飞世尔 mpk 1抗体（Biosources, 44-680G)被用于. Brain Res (2006) ncbi
兔 多克隆
赛默飞世尔 mpk 1抗体（BioSource, 44-680G)被用于. Arthritis Rheum (2005) ncbi
文章列表
  1. Roversi F, Pericole F, Machado Neto J, da Silva Santos Duarte A, Longhini A, Corrocher F, et al. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway. Biochim Biophys Acta Mol Basis Dis. 2017;1863:450-461 pubmed 出版商
  2. Caporali S, Alvino E, Lacal P, Levati L, Giurato G, Memoli D, et al. Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor. Int J Oncol. 2016;49:1164-74 pubmed 出版商
  3. Köchl R, Thelen F, Vanes L, Brazão T, Fountain K, Xie J, et al. WNK1 kinase balances T cell adhesion versus migration in vivo. Nat Immunol. 2016;17:1075-83 pubmed 出版商
  4. Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, et al. Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat Commun. 2016;7:11030 pubmed 出版商
  5. Wang J, Goetsch L, Tucker L, Zhang Q, Gonzalez A, Vaidya K, et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer. 2016;16:105 pubmed 出版商
  6. Fan S, Numata Y, Numata M. Endosomal Na+/H+ exchanger NHE5 influences MET recycling and cell migration. Mol Biol Cell. 2016;27:702-15 pubmed 出版商
  7. Shih M, Pan K, Cherng J. Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells. Int J Mol Sci. 2015;16:28800-11 pubmed 出版商
  8. Quintero Barceinas R, García Regalado A, Aréchaga Ocampo E, Villegas Sepúlveda N, González De la Rosa C. All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism. Biomed Res Int. 2015;2015:404368 pubmed 出版商
  9. Salas E, Roy S, Marsh T, Rubin B, Debnath J. Oxidative pentose phosphate pathway inhibition is a key determinant of antimalarial induced cancer cell death. Oncogene. 2016;35:2913-22 pubmed 出版商
  10. Graziani G, Artuso S, De Luca A, Muzi A, Rotili D, Scimeca M, et al. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib. Biochem Pharmacol. 2015;95:16-27 pubmed 出版商
  11. Cheng Z, Liu F, Zhu S, Tian H, Wang L, Wang Y. A rapid and convenient method for fluorescence analysis of in vitro cultivated metacestode vesicles from Echinococcus multilocularis. PLoS ONE. 2015;10:e0118215 pubmed 出版商
  12. Murrow L, Malhotra R, Debnath J. ATG12-ATG3 interacts with Alix to promote basal autophagic flux and late endosome function. Nat Cell Biol. 2015;17:300-10 pubmed 出版商
  13. Cheng Y, Chen P, Chiang H, Suen C, Hwang M, Lin T, et al. Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT. Cell Death Dis. 2015;6:e1584 pubmed 出版商
  14. Han P, Zhou X, Chang N, Xiao C, Yan S, Ren H, et al. Hydrogen peroxide primes heart regeneration with a derepression mechanism. Cell Res. 2014;24:1091-107 pubmed 出版商
  15. Linke R, Pries R, Könnecke M, Bruchhage K, Böscke R, Gebhard M, et al. The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps. Arch Immunol Ther Exp (Warsz). 2014;62:217-29 pubmed 出版商
  16. Bloch O, Amit Vazina M, Yona E, Molad Y, Rapoport M. Increased ERK and JNK activation and decreased ERK/JNK ratio are associated with long-term organ damage in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2014;53:1034-42 pubmed
  17. Wickert L, Blanchette J, Waldschmidt N, Bertics P, Denu J, Denlinger L, et al. The C-terminus of human nucleotide receptor P2X7 is critical for receptor oligomerization and N-linked glycosylation. PLoS ONE. 2013;8:e63789 pubmed 出版商
  18. Witte K, Schuh A, Hegermann J, Sarkeshik A, Mayers J, Schwarze K, et al. TFG-1 function in protein secretion and oncogenesis. Nat Cell Biol. 2011;13:550-8 pubmed 出版商
  19. Grassian A, Schafer Z, Brugge J. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells. J Biol Chem. 2011;286:79-90 pubmed 出版商
  20. Brusevold I, Husvik C, Schreurs O, Schenck K, Bryne M, Søland T. Induction of invasion in an organotypic oral cancer model by CoCl2, a hypoxia mimetic. Eur J Oral Sci. 2010;118:168-76 pubmed 出版商
  21. Yang L, Zhang Q, Zhou C, Yang F, Zhang Y, Wang R, et al. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS ONE. 2010;5:e9851 pubmed 出版商
  22. Lu Z, Cox Hipkin M, Windsor W, Boyapati A. 3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway. Mol Cancer Res. 2010;8:421-32 pubmed 出版商
  23. Søland T, Husvik C, Koppang H, Boysen M, Sandvik L, Clausen O, et al. A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas. J Oral Pathol Med. 2008;37:535-42 pubmed 出版商
  24. Rauh Adelmann C, Moskow J, Graham J, Yen L, Boucher J, Murphy C, et al. Quantitative measurement of epidermal growth factor receptor-mitogen-activated protein kinase signal transduction using a nine-plex, peptide-based immunoassay. Anal Biochem. 2008;375:255-64 pubmed 出版商
  25. Klees R, Salasznyk R, Ward D, Crone D, Williams W, Harris M, et al. Dissection of the osteogenic effects of laminin-332 utilizing specific LG domains: LG3 induces osteogenic differentiation, but not mineralization. Exp Cell Res. 2008;314:763-73 pubmed 出版商
  26. Salasznyk R, Klees R, Boskey A, Plopper G. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5. J Cell Biochem. 2007;100:499-514 pubmed
  27. Hao H, Schwaber J. Epidermal growth factor receptor induced Erk phosphorylation in the suprachiasmatic nucleus. Brain Res. 2006;1088:45-8 pubmed
  28. Carulli M, Ong V, Ponticos M, Shiwen X, Abraham D, Black C, et al. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation. Arthritis Rheum. 2005;52:3772-82 pubmed